Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Srinivasu Mudalagiriyappa"'
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
In recent years, fungal vaccine research emanated significant findings in the field of antifungal T-cell immunity. The generation of effector T cells is essential to combat many mucosal and systemic fungal infections. The development of antifungal me
Externí odkaz:
https://doaj.org/article/f9b748fcd88b460ba12a67451cd45da7
Publikováno v:
Cell reports. 41(4)
GM-CSF co-expressing T17 cells instigate pathologic inflammation during autoimmune disorders, but their function in immunity to infections is unclear. Here, we demonstrate the role of GM-CSF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb0ccb95bc151ff6aa389ea43cda3415
https://pubmed.ncbi.nlm.nih.gov/36288707
https://pubmed.ncbi.nlm.nih.gov/36288707
The global burden of fungal infections is alarming, primarily due to the increasing immune-compromised population. The immuno-preventive/therapeutic measures, including vaccines, are necessary to prevent or control fungal diseases. Identifying a prot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b40429e55ca3103debdbbfea176e4796
https://doi.org/10.1101/2022.03.31.486552
https://doi.org/10.1101/2022.03.31.486552
Autor:
Srinivasu Mudalagiriyappa, Jaishree Sharma, Miranda Vieson, Bruce S. Klein, Som Gowda Nanjappa
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3eb7dd492896360ef27757e06638c901
https://doi.org/10.2139/ssrn.4099074
https://doi.org/10.2139/ssrn.4099074
Publikováno v:
Cell Reports. 41:111543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71425dda52dbebea2618ac6cd58239a5
https://doi.org/10.1016/j.celrep.2022.111543
https://doi.org/10.1016/j.celrep.2022.111543
Publikováno v:
The Journal of Immunology. 208:58.34-58.34
Invasive fungal infections (IFI) are emerging diseases accounting for 1.7 million deaths and 150 million life-threatening diseases worldwide annually. The increased population of immunocompromised individuals and lack of arsenal of antifungal drugs n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::888011eb7fdf185de8f31013c43e29f3
https://doi.org/10.4049/jimmunol.208.supp.58.34
https://doi.org/10.4049/jimmunol.208.supp.58.34
Autor:
Som G. Nanjappa, Miranda D. Vieson, Adel M. Talaat, Srinivasu Mudalagiriyappa, Woo-Suk Choi, Thomas C Kelly, Jaishree Sharma, Hazem F. M. Abdelaal
Non-Tuberculous Mycobacteria (NTM) are ubiquitous in nature, present in soil and water, and cause primary leading to disseminated infections in immunocompromised individuals. NTM infections are surging in recent years due to an increase in an immune-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1861dfce77f3cc5348d709266d778370
https://doi.org/10.1101/2020.05.28.117663
https://doi.org/10.1101/2020.05.28.117663
Autor:
Gee W. Lau, Woo-Suk Choi, Shanny Hsuan Kuo, Srinivasu Mudalagiriyappa, Som G. Nanjappa, Carol Maddox, Aaron Sieve, Miranda D. Vieson, Alina Xiaoyu Yang
Publikováno v:
Am J Pathol
Pulmonary mycoses are difficult to treat and detrimental to patients. Fungal infections modulate the lung immune response, induce goblet cell hyperplasia and metaplasia, and mucus hypersecretion in the airways. Excessive mucus clogs small airways and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cccc1f514907021a49a541a5f4906af4
https://pubmed.ncbi.nlm.nih.gov/33069717
https://pubmed.ncbi.nlm.nih.gov/33069717
Publikováno v:
The Journal of Immunology. 206:99.25-99.25
Opportunistic fungal infections are rising at alarming rates in immunocompromised individuals. There is no licensed fungal vaccine available, nor there a clear understanding of the protective host responses. In a mouse model of fungal vaccine-immunit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89dcdb182887f04d4142c40577436b08
https://doi.org/10.4049/jimmunol.206.supp.99.25
https://doi.org/10.4049/jimmunol.206.supp.99.25
Publikováno v:
The Journal of Immunology. 206:16.06-16.06
Increased opportunistic fungal infections in immunocompromised patients and lack of effective therapeutic modalities caused millions of deaths worldwide. Further, there are no licensed vaccines available for such and for immune-sufficient individuals
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff020145e20fe9be68c2988da222c05b
https://doi.org/10.4049/jimmunol.206.supp.16.06
https://doi.org/10.4049/jimmunol.206.supp.16.06